Capecitabine FDA Link

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

Also Known As:

Xeloda; N(4)- pentyloxycarbonyl- 5'- deoxy- 5- fluorocytidine

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - Uracil: 1493
        Fluorouracil: 26711
        Capecitabine: 5152
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        Deoxycytidine: 307
        Capecitabine: 5152
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Deoxycytidine: 307
        Capecitabine: 5152
  - Deoxyribonucleosides: 34
    - Deoxycytidine: 307
      - Capecitabine: 5152

N Barak-Wigler Selected Research

N Barak-Wigler Research Topics

Disease

Drug/Important Bio-Agent (IBA)